FR3032615A1 - Composition antimicrobienne pour animaux - Google Patents
Composition antimicrobienne pour animaux Download PDFInfo
- Publication number
- FR3032615A1 FR3032615A1 FR1551166A FR1551166A FR3032615A1 FR 3032615 A1 FR3032615 A1 FR 3032615A1 FR 1551166 A FR1551166 A FR 1551166A FR 1551166 A FR1551166 A FR 1551166A FR 3032615 A1 FR3032615 A1 FR 3032615A1
- Authority
- FR
- France
- Prior art keywords
- composition
- composition according
- weight
- animals
- total weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 109
- 241001465754 Metazoa Species 0.000 title claims abstract description 21
- 230000000845 anti-microbial effect Effects 0.000 title claims abstract description 15
- 239000000839 emulsion Substances 0.000 claims abstract description 23
- BTSZTGGZJQFALU-UHFFFAOYSA-N piroctone olamine Chemical compound NCCO.CC(C)(C)CC(C)CC1=CC(C)=CC(=O)N1O BTSZTGGZJQFALU-UHFFFAOYSA-N 0.000 claims abstract description 21
- 229940081510 piroctone olamine Drugs 0.000 claims abstract description 21
- 239000003995 emulsifying agent Substances 0.000 claims abstract description 16
- 239000012071 phase Substances 0.000 claims abstract description 16
- 239000004480 active ingredient Substances 0.000 claims abstract description 12
- 238000005507 spraying Methods 0.000 claims abstract description 9
- 239000008346 aqueous phase Substances 0.000 claims abstract description 7
- 201000010099 disease Diseases 0.000 claims abstract description 7
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 7
- 230000000813 microbial effect Effects 0.000 claims abstract description 7
- 230000000699 topical effect Effects 0.000 claims abstract description 7
- 239000004599 antimicrobial Substances 0.000 claims abstract description 4
- 230000003449 preventive effect Effects 0.000 claims abstract description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 12
- 239000000341 volatile oil Substances 0.000 claims description 8
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 claims description 6
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 claims description 5
- 229960004308 acetylcysteine Drugs 0.000 claims description 5
- 229960005323 phenoxyethanol Drugs 0.000 claims description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 claims description 2
- 150000001252 acrylic acid derivatives Chemical class 0.000 claims description 2
- 229940106010 beheneth-25 Drugs 0.000 claims description 2
- 229920001577 copolymer Polymers 0.000 claims description 2
- 229920000642 polymer Polymers 0.000 claims description 2
- 239000004615 ingredient Substances 0.000 description 9
- 239000003921 oil Substances 0.000 description 7
- 241001299738 Malassezia pachydermatis Species 0.000 description 5
- 241000794282 Staphylococcus pseudintermedius Species 0.000 description 5
- 239000000499 gel Substances 0.000 description 5
- 235000019198 oils Nutrition 0.000 description 5
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 240000003553 Leptospermum scoparium Species 0.000 description 4
- 235000016887 Leptospermum scoparium Nutrition 0.000 description 4
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000844 anti-bacterial effect Effects 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 238000011534 incubation Methods 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 230000000843 anti-fungal effect Effects 0.000 description 3
- 244000052616 bacterial pathogen Species 0.000 description 3
- 238000010790 dilution Methods 0.000 description 3
- 239000012895 dilution Substances 0.000 description 3
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 3
- 238000009472 formulation Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 230000010363 phase shift Effects 0.000 description 3
- 238000011012 sanitization Methods 0.000 description 3
- 230000007928 solubilization Effects 0.000 description 3
- 238000005063 solubilization Methods 0.000 description 3
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical compound NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 241000282472 Canis lupus familiaris Species 0.000 description 2
- 241000282326 Felis catus Species 0.000 description 2
- 244000178870 Lavandula angustifolia Species 0.000 description 2
- 235000010663 Lavandula angustifolia Nutrition 0.000 description 2
- QQONPFPTGQHPMA-UHFFFAOYSA-N Propene Chemical group CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- 230000003113 alkalizing effect Effects 0.000 description 2
- 229940121375 antifungal agent Drugs 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000010419 fine particle Substances 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 238000000338 in vitro Methods 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- 239000001102 lavandula vera Substances 0.000 description 2
- 235000018219 lavender Nutrition 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000001717 pathogenic effect Effects 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 150000003839 salts Chemical group 0.000 description 2
- 239000002453 shampoo Substances 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 230000009974 thixotropic effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- XMAYWYJOQHXEEK-OZXSUGGESA-N (2R,4S)-ketoconazole Chemical compound C1CN(C(=O)C)CCN1C(C=C1)=CC=C1OC[C@@H]1O[C@@](CN2C=NC=C2)(C=2C(=CC(Cl)=CC=2)Cl)OC1 XMAYWYJOQHXEEK-OZXSUGGESA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- QWGRWMMWNDWRQN-UHFFFAOYSA-N 2-methylpropane-1,3-diol Chemical compound OCC(C)CO QWGRWMMWNDWRQN-UHFFFAOYSA-N 0.000 description 1
- 241001480043 Arthrodermataceae Species 0.000 description 1
- 241000222122 Candida albicans Species 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 208000001840 Dandruff Diseases 0.000 description 1
- 241000588914 Enterobacter Species 0.000 description 1
- 241000283086 Equidae Species 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 241000588748 Klebsiella Species 0.000 description 1
- 241001227551 Lavandula x intermedia Species 0.000 description 1
- 241000555676 Malassezia Species 0.000 description 1
- 241000893980 Microsporum canis Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000193996 Streptococcus pyogenes Species 0.000 description 1
- NSOXQYCFHDMMGV-UHFFFAOYSA-N Tetrakis(2-hydroxypropyl)ethylenediamine Chemical compound CC(O)CN(CC(C)O)CCN(CC(C)O)CC(C)O NSOXQYCFHDMMGV-UHFFFAOYSA-N 0.000 description 1
- 241001045770 Trichophyton mentagrophytes Species 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 239000003213 antiperspirant Substances 0.000 description 1
- 239000012736 aqueous medium Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 229940095731 candida albicans Drugs 0.000 description 1
- 229940048300 coco-caprylate Drugs 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000037304 dermatophytes Effects 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 230000002349 favourable effect Effects 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 229960004125 ketoconazole Drugs 0.000 description 1
- 238000009630 liquid culture Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- LVWZTYCIRDMTEY-UHFFFAOYSA-N metamizole Chemical compound O=C1C(N(CS(O)(=O)=O)C)=C(C)N(C)N1C1=CC=CC=C1 LVWZTYCIRDMTEY-UHFFFAOYSA-N 0.000 description 1
- 229940100573 methylpropanediol Drugs 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 108700019599 monomethylolglycine Proteins 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- RGCLLPNLLBQHPF-HJWRWDBZSA-N phosphamidon Chemical class CCN(CC)C(=O)C(\Cl)=C(/C)OP(=O)(OC)OC RGCLLPNLLBQHPF-HJWRWDBZSA-N 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- GGOZGYRTNQBSSA-UHFFFAOYSA-N pyridine-2,3-diol Chemical compound OC1=CC=CN=C1O GGOZGYRTNQBSSA-UHFFFAOYSA-N 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 229940101011 sodium hydroxymethylglycinate Drugs 0.000 description 1
- CITBNDNUEPMTFC-UHFFFAOYSA-M sodium;2-(hydroxymethylamino)acetate Chemical compound [Na+].OCNCC([O-])=O CITBNDNUEPMTFC-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000003981 vehicle Substances 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4412—Non condensed pyridines; Hydrogenated derivatives thereof having oxo groups directly attached to the heterocyclic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/133—Amines having hydroxy groups, e.g. sphingosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Communicable Diseases (AREA)
- Dispersion Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (12)
- REVENDICATIONS1. Composition dermatologique et/ou dermocosmétique antimicrobienne à usage topique pour animaux, caractérisée en ce qu'elle se présente sous forme d'une émulsion pulvérisable comprenant une phase aqueuse et une phase grasse, ladite composition contenant de la piroctone olamine en tant qu'ingrédient actif, et un agent émulsionnant.
- 2. Composition selon la revendication 1, contenant en outre un agent viscosant.
- 3. Composition selon la revendication 2, contenant une quantité comprise entre 0,5 et 5 % en poids, préférentiellement entre 1 et 2 % en poids, par rapport au poids total de la composition, dudit agent viscosant.
- 4. Composition selon l'une quelconque des revendications 2 à 3, dans laquelle l'agent viscosant est un polymère du type à motifs acrylates, notamment un copolymère d'acrylates et de méthacrylate de béhéneth-25.
- 5. Composition selon l'une quelconque des revendications 1 à 4, contenant au moins une des quantités en composant suivantes, lesdites quantités étant exprimées en % en poids, par rapport au poids total de la composition : - 0,02 à 1 % de piroctone olamine, - 0,5 à 5 %, de préférence 0,8 à 3 % d'agent émulsionnant, - 0,3 à 30 %, de préférence 0,3 à 10 % de phase grasse.
- 6. Composition selon l'une quelconque des revendications 1 à 5, dans laquelle l'agent émulsionnant est du type capable de former une émulsion lamellaire stable.
- 7. Composition selon l'une quelconque des revendications 1 à 6, 3032615 15 contenant de la N-acétylcystéine, de préférence dans une quantité comprise entre 1 et 5 % en poids par rapport au poids total de la composition.
- 8. Composition selon l'une quelconque des revendications 1 à 7, contenant du phénoxyéthanol, de préférence dans une quantité comprise entre 5 0 et 2 % en poids par rapport au poids total de la composition.
- 9. Composition selon l'une quelconque des revendications 1 à 8, dans laquelle la phase aqueuse contient au moins un alcool, de préférence dans une quantité comprise entre 0 et 30 %, préférentiellement comprise entre 5 et 15 %, en poids par rapport au poids total de la composition. 10
- 10. Composition selon l'une quelconque des revendications 1 à 9, contenant au moins une huile essentielle à action antimicrobienne.
- 11. Composition selon l'une quelconque des revendications 1 à 10, conditionnée dans un dispositif équipé de moyens de pulvérisation de ladite composition. 15
- 12. Composition selon l'une quelconque des revendications 1 à 11, pour son utilisation pour le traitement curatif et/ou préventif par voie topique d'affections microbiennes cutanées chez l'animal.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1551166A FR3032615B1 (fr) | 2015-02-12 | 2015-02-12 | Composition antimicrobienne pour animaux |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR1551166 | 2015-02-12 | ||
FR1551166A FR3032615B1 (fr) | 2015-02-12 | 2015-02-12 | Composition antimicrobienne pour animaux |
Publications (2)
Publication Number | Publication Date |
---|---|
FR3032615A1 true FR3032615A1 (fr) | 2016-08-19 |
FR3032615B1 FR3032615B1 (fr) | 2018-05-25 |
Family
ID=53177620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
FR1551166A Active FR3032615B1 (fr) | 2015-02-12 | 2015-02-12 | Composition antimicrobienne pour animaux |
Country Status (1)
Country | Link |
---|---|
FR (1) | FR3032615B1 (fr) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090170932A1 (en) * | 2007-12-31 | 2009-07-02 | Tyco Healthcare Group Lp | Disinfectant compositions, methods and systems |
DE102010013275A1 (de) * | 2010-03-29 | 2011-09-29 | Beiersdorf Ag | Mikrobiologisch stabile anwendungsfreundliche W/O-Zubereitungen |
-
2015
- 2015-02-12 FR FR1551166A patent/FR3032615B1/fr active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090170932A1 (en) * | 2007-12-31 | 2009-07-02 | Tyco Healthcare Group Lp | Disinfectant compositions, methods and systems |
DE102010013275A1 (de) * | 2010-03-29 | 2011-09-29 | Beiersdorf Ag | Mikrobiologisch stabile anwendungsfreundliche W/O-Zubereitungen |
Non-Patent Citations (1)
Title |
---|
LABORATOIRES DERMATOLOGIQUES URIAGE: "Cold Cream", GNPD; MINTEL, 1 December 2009 (2009-12-01), XP002687972 * |
Also Published As
Publication number | Publication date |
---|---|
FR3032615B1 (fr) | 2018-05-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP2821386B1 (fr) | Composition cosmétique, dermatologique ou pharmaceutique comprenant au moins un dérivé de vanilline comme conservateur | |
WO2004028520A1 (fr) | Bactericides antiseptiques et cosmetiques, medicaments et produits alimentaires contenant ces bactericides antiseptiques | |
CN105411923B (zh) | 含有葡萄柚籽提取物的天然广谱防腐组合物及其应用 | |
KR101189344B1 (ko) | 자가-보존성 스킨케어 조성물 | |
US20210093593A1 (en) | Antiseptic, antiseborrheic and exfoliating composition to remove or prevent acne | |
FR2866564A1 (fr) | Desinfectant antiseptique et produit cosmetique, produit pharmaceutique ou aliment le contenant | |
CA2878496C (fr) | Utilisation d'un extrait de myrte en tant qu'agent anti-biofilm vis-a-vis de p. acnes | |
KR102272901B1 (ko) | 메조-2,3-부탄디올을 방부제로서 함유하는 피부 외용제 조성물 | |
KR102412958B1 (ko) | 폴리글리세린-3을 함유하는 항균 또는 보존용 조성물 | |
Manzoor et al. | Nanosizing of Lavender, Basil, and Clove Essential Oils into Microemulsions for Enhanced Antioxidant Potential and Antibacterial and Antibiofilm Activities | |
EP2200582B1 (fr) | Utilisation d'excipients en tant que conservateurs et composition pharmaceutique les comprenant | |
FR2967054A1 (fr) | Systeme conservateur | |
US20100111994A1 (en) | Anti-bacterial composition and method of using same | |
Siegert | Preservative trends in wet wipes | |
CA3187137C (fr) | Lotion topique ayant des proprietes desinfectantes | |
FR3032615A1 (fr) | Composition antimicrobienne pour animaux | |
FR2866234A1 (fr) | Desinfectant antiseptique et produit cosmetique, produit pharmaceutique ou aliment le contenant | |
CN107669513A (zh) | 一种具有护肤抑菌作用的橄榄油/ve微乳凝胶及其制备方法 | |
EP4258884A1 (fr) | Composition liquide antimicrobienne et son utilisation comme activateur de conservateur de produits cosmetiques | |
FR2857222A1 (fr) | Microbicide antiseptique, et cosmetique, medicament et aliment incorporant ledit microbicide antiseptique | |
JP2004300143A (ja) | 防腐殺菌剤並びに該防腐殺菌剤を配合した化粧料、医薬品及び食品 | |
FR3068208B1 (fr) | Melange antimicrobien contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et de l’acide dehydroacetique ou l’un de ses sels , et composition cosmetique le contenant | |
FR2902290A1 (fr) | Nouvel agent conservateur anti bacterien et son procede d'obtention | |
JP5019093B2 (ja) | 抗菌組成物 | |
FR3068218A1 (fr) | Melange antimicrobien contenant du 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one et de la chlorphenesine, et composition cosmetique le contenant |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PLFP | Fee payment |
Year of fee payment: 2 |
|
PLSC | Publication of the preliminary search report |
Effective date: 20160819 |
|
PLFP | Fee payment |
Year of fee payment: 3 |
|
PLFP | Fee payment |
Year of fee payment: 4 |
|
PLFP | Fee payment |
Year of fee payment: 6 |
|
PLFP | Fee payment |
Year of fee payment: 7 |
|
PLFP | Fee payment |
Year of fee payment: 8 |
|
PLFP | Fee payment |
Year of fee payment: 9 |
|
PLFP | Fee payment |
Year of fee payment: 10 |
|
CA | Change of address |
Effective date: 20240610 |
|
CD | Change of name or company name |
Owner name: NEXTMUNE, FR Effective date: 20240610 |
|
CA | Change of address |
Effective date: 20240704 |